Delivery Order SPE2DB22D2007-SPE2DB24FJ0NX
- Not listed
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $120,846.21 firm-fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a specialty pharmaceutical product, to support military treatment programs and facilities worldwide. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,496.44, is for the provision of the pharmaceutical product BIKTARVY 50-200-25 MG TABLET UU 30S. This delivery order is part of a larger indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds with DLA, valued at up to $999,999,999.00 and running...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $19,215.93 firm fixed price delivery order is for the provision of BIKTARVY 50-200-25 MG TABLET UU 30S, a specialty pharmaceutical product. The award is associated with a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen Drug Corp...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $19,671.99 firm fixed price contract is for the delivery of the HIV medication BIKTARVY 50-200-25 MG TABLET in 30-count packages. This award is a part of Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, is a delivery order valued at $1,496.44 for the supply of the antiretroviral medication BIKTARVY. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, with a performance period through March 11, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 indefinite delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $94,322.57 firm fixed price delivery order is for the supply of BIKTARVY 50-200-25 mg tablets, a specialty pharmaceutical product. The contract is not designated as a set-aside and represents a task order under a larger indefinite delivery contract (IDC) held by...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $55,065.44, is a Firm Fixed Price Delivery Order for the supply of BIKTARVY 50-200-25 MG TABLET. The contract has an ultimate completion date of January 16, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation mentioned. The award is...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $84,517.00, is for the provision of BIKTARVY 50-200-25 MG TABLET in support of military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distribution company Amerisourcebergen Corporation, is a delivery order contract from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of BIKTARVY 50-200-25 MG TABLET in 30-count packages. The contract has a ceiling value of $77,849.82 and a period of performance through March 28, 2024. It is a firm fixed price contract with no set-aside designation....
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $10,034.71 firm fixed-price delivery order contract is for the supply of BIKTARVY 50-200-25 MG TABLET, a medication. The contract has a performance period ending on May 14, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ0NXDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $19,047.64, is for the delivery of BIKTARVY 50-200-25 mg tablets to support military treatment programs and facilities. Amerisourcebergen Drug Corp serves as the prime contractor on this award, which is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC represents the primary contract vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical, supporting the Department of Defense. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.0k | 3/14/24 |